(Press-News.org) WASHINGTON, April 18, 2013 – Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 — and that drug was approved two and a half years ago.
In a new report, published online today in Clinical Infectious Diseases, IDSA identified only seven new drugs in development for the treatment of infections caused by multidrug-resistant gram-negative bacilli (GNB) bacteria. GNB, which include the "nightmare bacteria" to which the Centers for Disease Control and Prevention (CDC) alerted the public in its March 2013 Vital Signs report, represent the most pressing medical need. Importantly, there is no guarantee that any of the drugs currently in development to treat GNB will make it across the finish line to FDA approval and none of them will work against the most resistant bugs we're worried about today.
"In the past, the 10 x '20 goal would have been considered modest, but today the barriers to approval of nine additional antibiotics by 2020 seem insurmountable," said Henry Chambers, MD, chair of IDSA's Antimicrobial Resistance Committee (ARC). "Some progress has been made in the development of new antibiotics, but it's not nearly enough, and we absolutely must accelerate our efforts."
"We're losing ground because we are not developing new drugs in pace with superbugs' ability to develop resistance to them. We're on the precipice of returning to the dark days before antibiotics enabled safer surgery, chemotherapy and the care of premature infants. We're all at risk," said Helen W. Boucher, MD, lead author of the policy paper and a member of IDSA's Board of Directors and ARC.
Entitled "10 x '20 Progress: Development of New Drugs Active against Gram-negative Bacilli: An Update from the Infectious Diseases Society of America," the paper outlines actions that must be taken to address the synergistic crises of an anemic antibiotic pipeline coupled with an explosion in multi-drug resistant pathogens. A multi-pronged approach is needed, including new economic incentives to encourage antibiotic research and development (R&D); clarification of FDA's requirements for antibiotic approval; increased research funding; improved infection prevention; and new public health efforts including better data collection and surveillance of drug resistance and use of antibiotics. We also need to encourage "antibiotic stewardship," which includes measures that health care facilities, providers and even patients can take to preserve the life-saving power of antibiotics by limiting their inappropriate use.
IDSA leaders have been exploring with other stakeholders specific solutions to address the pipeline problem including the creation of a Limited Population Antibacterial Drug (LPAD) approval pathway to speed drugs to approval as well as new R&D tax credits and reimbursement models. Congressional Republican leaders in the U.S. House of Representatives announced last month their intent to make fixing the antibiotic R&D pipeline a priority for the 113th Congress.
Ironically, at this urgent time of greatest need, the number of pharmaceutical companies investing in antibiotic R&D has plummeted. Pharmaceutical companies typically put R&D resources into the development of chronic disease drugs – including those to treat high cholesterol, diabetes, and cancer – which provide significant financial rewards, partly because they are intended to be taken for long periods of time. Antibiotics, which are intended to be taken for short courses, just can't compete. The results are playing out in real time, with the smaller pharmaceutical company Polymedix – which has one of the seven drugs in development noted in the 10 x '20 paper – filing for bankruptcy protection in early April 2013. Moreover, the policy update reports that only four large multinational companies remain in antibiotic R&D. One of these, AstraZeneca, which has two of the seven drugs in development, plans to reduce its future investments in antibiotics, its CEO, Pascal Soriot, recently announced. The current pipeline of antibiotics is fragile indeed, and the dwindling roster of antibiotic developers has dire consequences for public health, patient care and national security.
New antibiotics are critically necessary to save the lives of people such as Josh Nahum, a healthy 27-year-old man who died from an overwhelming Enterobacter aerogenes infection as he was recovering in the hospital after a skydiving accident. Although his doctors tried desperately to save Josh, they ran out of antibiotics to treat this virulent bug. Read more about Josh's story and the experiences of others whose lives have been devastated by antibiotic resistance: http://www.idsociety.org/Joshs_Story.aspx.
IDSA first warned of the looming antibiotic apocalypse with its 2004 report, "Bad Bugs, No Drugs." Nearly 50 other medical societies and organizations, including the American Medical Association, have endorsed the 10 x '20 initiative so far.
"IDSA is committed to ensuring proper use of currently-available antibiotics to make certain we can continue to count on them. But that is not enough. Simply put, the antibiotic pipeline is on life support and novel solutions are required to resuscitate it – now," said IDSA President David A. Relman, MD. "In the past year, the heads of CDC and the World Health Organization, along with the United Kingdom's chief medical officer, have all sounded the alarm about rising rates of antibiotic resistance. The lack of new antibiotics to treat these potentially life-threatening infections signals the end of modern medicine as we know it."
###
To see the policy update, which appears in the May 15 issue of Clinical Infectious Diseases (CID), contact Jerica Pitts (jpitts@pcipr.com) at 312-558-1770. See also a fact sheet on antimicrobial resistance here: http://www.idsociety.org/AntibioticResistanceFactSheet-April2013.pdf.
EDITOR'S NOTE: Although the paper published in CID recognizes two drugs approved by the FDA since 2009, the 10 x '20 Initiative was launched in April 2010 following the approval of one of these drugs.
The Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, patient care, prevention, and public health. The Society, which has more than 10,000 members, was founded in 1963 and is based in Arlington, Va. For more information, see http://www.idsociety.org.
Despite superbug crisis, progress in antibiotic development 'alarmingly elusive'
Policy update: Time dwindling to meet IDSA goal of 10 new antibiotics by 2020
2013-04-18
ELSE PRESS RELEASES FROM THIS DATE:
Screening breast ultrasound detects cancers missed on mammography in women with dense breasts
2013-04-18
Screening breast ultrasound performed after mammography on women with greater than 50% breast density detects an additional 3.4 cancers or high risk lesions per one thousand woman screened, a detection rate just under that of screening mammography alone for women with less dense breasts, a new study shows. Screening mammography detects 4-5 cancers per thousand women screened.
The study, conducted in conjunction with seven Connecticut radiology practices, included 19,745 women who had dense breasts and "normal" mammograms.
Sixty-seven cancers were found, said Dr. Sarah ...
Fascinating rhythm: The brain's 'slow waves'
2013-04-18
New findings clarify where and how the brain's "slow waves" originate. These rhythmic signal pulses, which sweep through the brain during deep sleep at the rate of about one cycle per second, are assumed to play a role in processes such as consolidation of memory. For the first time, researchers have shown conclusively that slow waves start in the cerebral cortex, the part of the brain responsible for cognitive functions. They also found that such a wave can be set in motion by a tiny cluster of neurons.
"The brain is a rhythm machine, producing all kinds of rhythms all ...
California real estate disputes: Partition in kind vs. partition by sale
2013-04-18
California real estate disputes: Partition in kind vs. partition by sale
Article provided by Law Offices of H. Michael Soroy
Visit us at http://www.soroy.com/
When co-owners of real estate disagree about how to use and maintain their shared property, it sometimes becomes necessary to settle the dispute by requesting that the court sever the co-ownership in a process known as partition. In California, a co-owner of property typically may initiate a partition action at any time.
Partition in kind
One way that the courts may resolve a partition action in California ...
SCOTUS holds narcotic dogs can provide cause to search vehicle
2013-04-18
SCOTUS holds narcotic dogs can provide cause to search vehicle
Article provided by Traffic Ticket Pros
Visit us at http://www.trafficticketpros.com
The Supreme Court of the United States, or SCOTUS, recently reviewed a case involving the use of a drug sniffing dog. The case, out of Florida, focused specifically on whether a narcotic dog's alert can be used to provide probable cause for the search of a vehicle. The answer: yes.
The case, Florida v. Harris, looked more specifically into what factors were needed to establish the reliability of a narcotics dog. In ...
Doctor charged as head of oxycodone ring
2013-04-18
Doctor charged as head of oxycodone ring
Article provided by Watson Law
Visit us at http://www.watsonlawpeoria.com
An investigation in New York has led to the arrest of a doctor as the head of a major oxycodone trafficking scheme. According to the Drug Enforcement Administration, Dr. Hector Castro, his office manager, Patricia Valera and several others were in charge of a ring responsible for the distribution of approximately half a million oxycodone pills worth at least $10 million.
Castro became a person of interest in 2011, after New Jersey authorities discovered ...
Dog sniff search ruled unconstitutional
2013-04-18
Dog sniff search ruled unconstitutional
Article provided by Watson Law
Visit us at http://www.watsonlawpeoria.com
The U.S. Supreme Court recently ruled that law enforcement officers may not bring drug sniffing dogs onto a suspect's property to search for evidence without first getting a warrant. The Court's 5-4 decision in Florida v. Jardines is likely to impact the way that police officers conduct investigations of possible crimes involving drugs.
Facts of Jardines
On the morning of December 5, 2006, Miami police officers set up a surveillance operation outside ...
Pennsylvania commercial and residential real estate market is heating up
2013-04-18
Pennsylvania commercial and residential real estate market is heating up
Article provided by Kaplin Stewart Meloff Reiter & Stein, P.C.
Visit us at http://www.kaplaw.com
According to West Penn Multi-List, Inc., a multiple listing service company for some Pennsylvania realtors, the real estate market appears to be picking up in the state. Realtors are seeing residential homes selling more quickly and for higher prices than they were a year ago.
In Philadelphia, multifamily and other commercial real estate is moving as well. The Philadelphia Business Journal ...
Creating a living will has numerous benefits
2013-04-18
Creating a living will has numerous benefits
Article provided by Teiger Law Center
Visit us at http://www.teigerlaw.com
Deciding to create a living will is one of the best decisions an individual can make. A living will ensures that the proper decisions regarding medical treatment are made when an individual can no longer communicate these wishes himself or herself.
The absence of a living will can create conflicts within families
According to CBS News, a Pew research study found that only 29 percent of people currently have a living will. Although most individuals ...
Traumatic brain injuries result in severe consequences
2013-04-18
Traumatic brain injuries result in severe consequences
Article provided by Kenneth W. Drake & Associates Law Offices
Visit us at http://www.sfvinjurylaw.com
Brain injuries, particularly traumatic brain injuries, are commonly caused by the negligence of another, such as a driver's negligence that causes a car accident. Surgical errors that cause nerve damage are another common cause of TBIs -- and may result in a medical malpractice suit.
TBIs can be mild, moderate or severe
According to the Centers for Disease Control and Prevention, TBIs are also commonly ...
Why teen drivers are the most dangerous on the road
2013-04-18
Why teen drivers are the most dangerous on the road
Article provided by Weik, Nitsche, & Dougherty
Visit us at http://www.weiknitsche.com
Learning to drive a car can be an exciting time for a teenager -- and a frightening time for his or her parents. And statistics show that parents really do have good reasons to be concerned. According to the Centers for Disease Control and Prevention, in 2010 alone, there were 282,000 teenagers injured in car accidents and another 2,700 were killed.
Common causes for accidents involving teen drivers
There are several ...
LAST 30 PRESS RELEASES:
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes
CTE and normal aging are difficult to distinguish, new study finds
Molecular arms race: How the genome defends itself against internal enemies
Tiny chip speeds up antibody mapping for faster vaccine design
KTU experts reveal why cultural heritage is important for community unity
More misfolded proteins than previously known may contribute to Alzheimer’s and dementia
“Too much going on”: Autistic adults overwhelmed by non-verbal social cues
What’s driving America’s deep freezes in a warming world?
A key role of brain protein in learning and memory is deciphered by scientists
Heart attacks don’t follow a Hollywood script
Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories
Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds
Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%
Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR
New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications
State gun laws and firearm-related homicides and suicides
Use of tobacco and cannabis following state-level cannabis legalization
Long-term obesity and biological aging in young adults
Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement
Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development
A technological breakthrough for ultra-fast and greener AI
Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption
Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications
[Press-News.org] Despite superbug crisis, progress in antibiotic development 'alarmingly elusive'Policy update: Time dwindling to meet IDSA goal of 10 new antibiotics by 2020